Ophthalmic Goods Industry - SEC Form 4 Insider Trading Screener
Manufacturing Sector - Specialty Instruments - Ophthalmic Goods
36 results - 
- 
- 
- 
- 
- 
- - - - - | TC | cnt | 1d | 1w | 1m | 6m |
X |
Filing Date |
Trade Date |
Ticker |
Company | Insider Name | Insider Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2020-10-08 | COO | Cooper Companies, Inc. | Auerbach Robert D | Special Advisor to the CEO | S - Sale | $350.00 | -2,538 | 1,403 | -64% | -$888,300 | ||||||
| D | 2020-10-06 | COO | Cooper Companies, Inc. | Petersmeyer Gary S | Dir | S - Sale+OE | $348.54 | -1,000 | 1,338 | -43% | -$348,540 | |||||
| D | 2020-09-16 | COO | Cooper Companies, Inc. | Lindell Jody S | Dir | S - Sale+OE | $338.69 | -6,500 | 37,858 | -15% | -$2,201,453 | |||||
| DM | 2020-09-14 | STAA | Staar Surgical Co | Holliday Keith | CTO | S - Sale+OE | $53.32 | -72,015 | 19,332 | -79% | -$3,840,158 | |||||
2020-09-09 | STAA | Staar Surgical Co | Moore John C | Dir | S - Sale | $52.04 | -137,331 | 23,504 | -85% | -$7,146,705 | ||||||
| A | 2020-08-10 | EYE | National Vision Holdings, Inc. | Peeler D Randolph | Dir | P - Purchase | $35.23 | +28,410 | 71,277 | +66% | +$1,000,938 | |||||
| D | 2020-08-10 | STAA | Staar Surgical Co | Hayashida Jon K. | VP, Global Clinical, Medical | S - Sale+OE | $51.22 | -41,602 | 10,794 | -79% | -$2,130,854 | |||||
2020-07-08 | COO | Cooper Companies, Inc. | White Albert G III | Pres, CEO | P - Purchase | $278.23 | +1,000 | 41,430 | +2% | +$278,230 | ||||||
2020-07-08 | COO | Cooper Companies, Inc. | Sheffield Holly R | EVP, CSO | P - Purchase | $280.12 | +889 | 2,699 | +49% | +$249,024 | ||||||
| D | 2020-06-15 | STAA | Staar Surgical Co | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | S - Sale+OE | $44.07 | -39,215 | 127,950 | -23% | -$1,728,205 | |||||
2020-06-12 | COO | Cooper Companies, Inc. | Sheffield Holly R | EVP, CSO | P - Purchase | $283.18 | +880 | 1,810 | +95% | +$249,198 | ||||||
2020-06-11 | COO | Cooper Companies, Inc. | Ricupati Agostino | SVP, Fin, Tax; Chief Actg Off | P - Purchase | $281.47 | +1,000 | 1,800 | +125% | +$281,470 | ||||||
| D | 2020-06-10 | STAA | Staar Surgical Co | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | S - Sale+OE | $44.00 | -785 | 127,950 | -1% | -$34,540 | |||||
| D | 2020-05-21 | STAA | Staar Surgical Co | Gesten Samuel J | GC | S - Sale+OE | $40.00 | -192,522 | 41,185 | -82% | -$7,700,880 | |||||
| D | 2020-05-15 | STAA | Staar Surgical Co | Holliday Keith | CTO | S - Sale+OE | $37.69 | -25,000 | 28,447 | -47% | -$942,250 | |||||
| D | 2020-05-11 | STAA | Staar Surgical Co | Hayashida Jon K. | VP, Global Clinical, Medical | S - Sale+OE | $39.11 | -46,563 | 10,794 | -81% | -$1,821,079 | |||||
| D | 2020-05-11 | STAA | Staar Surgical Co | Francese James E | SVP, Comm. Ops., NA, APAC | S - Sale+OE | $39.06 | -18,856 | 51,133 | -27% | -$736,515 | |||||
| D | 2020-05-11 | STAA | Staar Surgical Co | Hansen Graydon C. | SVP, Global Operations | S - Sale+OE | $39.02 | -18,189 | 21,553 | -46% | -$709,708 | |||||
| D | 2020-03-23 | STAA | Staar Surgical Co | Hayashida Jon K. | VP, Global Clinical, Medical | S - Sale+OE | $26.83 | -2,813 | 10,794 | -21% | -$75,473 | |||||
| D | 2020-03-23 | STAA | Staar Surgical Co | Hansen Graydon C. | SVP, Global Operations | S - Sale+OE | $27.42 | -2,813 | 19,459 | -13% | -$77,132 | |||||
| D | 2020-03-23 | STAA | Staar Surgical Co | Gesten Samuel J | GC | S - Sale+OE | $27.42 | -2,742 | 41,185 | -6% | -$75,186 | |||||
| D | 2020-03-23 | STAA | Staar Surgical Co | Francese James E | SVP, Comm. Ops., NA, APAC | S - Sale+OE | $26.77 | -2,250 | 44,466 | -5% | -$60,233 | |||||
2020-03-23 | STAA | Staar Surgical Co | Andrews Deborah J | CFO | S - Sale | $27.42 | -834 | 31,267 | -3% | -$22,868 | ||||||
2020-01-23 | EYE | National Vision Holdings, Inc. | Fahs L Reade | CEO | S - Sale | $36.50 | -75,000 | 501,467 | -13% | -$2,737,500 | ||||||
| D | 2020-01-21 | STAA | Staar Surgical Co | Andrews Deborah J | CFO | S - Sale+OE | $42.20 | -106,604 | 32,101 | -77% | -$4,498,689 | |||||
| D | 2020-01-06 | COO | Cooper Companies, Inc. | Lindell Jody S | Dir | S - Sale+OE | $321.01 | -3,500 | 18,804 | -16% | -$1,123,534 | |||||
2020-01-06 | COO | Cooper Companies, Inc. | Petersmeyer Gary S | Dir | S - Sale | $322.29 | -250 | 1,338 | -16% | -$80,573 | ||||||
| D | 2020-01-02 | COO | Cooper Companies, Inc. | Kalkstein Michael | Dir | S - Sale+OE | $320.35 | -9,500 | 5,838 | -62% | -$3,043,319 | |||||
| DM | 2019-12-17 | EYE | National Vision Holdings, Inc. | Moore Patrick R. | SVP, CFO | S - Sale+OE | $32.00 | -70,000 | 4,500 | -94% | -$2,240,000 | |||||
| D | 2019-12-05 | STAA | Staar Surgical Co | Hayashida Jon K. | VP, Global Clinical, Medical | S - Sale+OE | $37.20 | -47,408 | 6,250 | -88% | -$1,763,619 | |||||
| D | 2019-12-04 | STAA | Staar Surgical Co | Blickensdoerfer Hans-Martin | SVP, Comm. Ops, China | S - Sale+OE | $38.15 | -45,000 | 124,200 | -27% | -$1,716,750 | |||||
| D | 2019-11-20 | STAA | Staar Surgical Co | Hansen Graydon C. | SVP, Global Operations | S - Sale+OE | $35.02 | -17,083 | 22,272 | -43% | -$598,247 | |||||
2019-11-14 | STAA | Staar Surgical Co | Andrews Deborah J | CFO | S - Sale | $34.68 | -4,167 | 32,101 | -11% | -$144,512 | ||||||
2019-11-14 | STAA | Staar Surgical Co | Barnes Scott D | Chief Medical Officer | S - Sale | $34.93 | -1,583 | 11,032 | -13% | -$55,294 | ||||||
2019-11-11 | EYE | National Vision Holdings, Inc. | Taylor Thomas V | Dir | P - Purchase | $27.67 | +3,610 | 9,339 | +63% | +$99,891 | ||||||
| M | 2019-11-04 | STAA | Staar Surgical Co | Holliday Keith | CTO | S - Sale | $35.00 | -16,541 | 14,323 | -54% | -$578,935 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |